Lung CT screening captures far more than lungs — triaging coronary calcium and other incidental findings without derailing the primary screening goal
Low-dose CT for lung cancer screening is optimized to detect pulmonary nodules, but the acquired volume physically spans from the lower neck to the upper abdomen. Every scan therefore partially images the heart and coronary arteries, thyroid, great vessels, esophagus, adrenal glands, upper liver and spleen, and the thoracic skeleton — any of which can harbor an incidental finding that has nothing to do with lung cancer.
Lung cancer screening CT protocols are designed around nodule detection: low radiation dose, thin-slice reconstruction, and a field of view large enough to guarantee complete lung coverage. That same field of view, however, is not anatomically confined to lung tissue.
Routinely captured, at least in part, on every scan: • Heart and coronary arteries — often with visible calcification • Thyroid gland (lower neck cuts) • Great vessels, mediastinum, esophagus • Adrenal glands and upper poles of kidneys • Upper liver and spleen • Ribs, spine, and sternum
Because these structures are seen on essentially every study, incidental findings are not a rare edge case — they are an expected, recurring output of the screening program that radiologists and referring clinicians must have a standard process for handling.
The central operational tension: a screening program exists to find lung cancer early without excessive downstream harm. Incidental findings elsewhere can add clinical value (e.g., catching a cardiovascular risk marker) but can also generate unnecessary anxiety, further imaging, and cost if mismanaged. The remaining stages of this simulator walk through how programs resolve that tension.
Coronary artery calcium is visualized on essentially every non-gated lung screening CT, because the heart sits within the standard scan volume — making it the single most common and most actionable incidental finding in these programs.
Because non-gated chest CT reliably visualizes the coronary arteries, incidentally detected coronary artery calcium (CAC) has become one of the most clinically valuable "side effects" of lung cancer screening. Unlike many incidental findings, CAC has a well-established evidence base linking it to atherosclerotic cardiovascular disease risk — meaning its detection can meaningfully change patient management, not just generate more imaging.
Lung screening and cardiovascular risk share a root cause: the population eligible for lung cancer screening (long-term, heavy smokers, typically 50+) is also a population at elevated cardiovascular risk. Coronary artery calcium is a direct marker of coronary atherosclerotic plaque burden and is one of the strongest available predictors of future cardiovascular events — independent of, and often complementary to, traditional risk calculators.
Because the coronary arteries fall within the scan volume regardless of intent, radiologists can assess and report calcification without any additional radiation dose or scan time. This has led professional societies to recommend systematic — not incidental or ad hoc — reporting of CAC on every lung screening CT.
Practical grading (ordinal visual scale commonly used on non-gated CT): • None — no visible calcification • Mild — small calcific foci in one or two coronary territories • Moderate — multiple or larger calcific deposits • Severe — extensive, confluent calcification across multiple vessels
Severe CAC identified incidentally has been shown to meaningfully reclassify patients' cardiovascular risk category, prompting statin therapy or further cardiology evaluation that would not otherwise have been triggered by routine primary care risk assessment alone.
Because both lung cancer and coronary artery disease share smoking as a dominant risk factor, coronary calcium is not a tangential curiosity in this population — it is a second, high-yield screening signal riding along on the same scan.
Not every incidental finding deserves a referral. Effective incidental finding management depends on a deliberate triage step that separates findings requiring further workup from the far larger number of trivial, benign-appearing findings — protecting patients from the cascade of anxiety, additional imaging, biopsies, and cost that over-referral produces, while still catching the minority of findings that matter.
Triage criteria vary by organ but generally weigh: size, growth potential, characteristic benign appearance, and established natural history.
Commonly insignificant, no-action findings: • Simple renal or hepatic cysts with classic benign imaging features • Small, stable-appearing granulomas or calcified lymph nodes • Degenerative spine and rib changes • Small, indeterminate findings well below a size threshold that warrants follow-up
Potentially significant findings warranting further evaluation: • Adrenal nodules with atypical imaging features or above a size threshold • Thyroid nodules meeting size/appearance criteria for further ultrasound • Hepatic or renal lesions with concerning features (irregular margins, enhancement pattern) • New or enlarging findings compared to a prior scan • Severe coronary artery calcification (handled via the cardiovascular pathway, Stage 2)
The triage decision determines the entire downstream pathway: an insignificant finding is simply documented and requires no patient-facing action, while a significant finding triggers a specific recommended next step (dedicated imaging, laboratory workup, or specialist referral) that must be clearly communicated.
Over-referral is a real harm, not just an inefficiency: unnecessary follow-up imaging and biopsies for findings that were never going to be clinically important generate patient anxiety, cost, and — occasionally — complications from invasive workup of a benign finding.
Ad hoc narrative mentions of incidental findings ("there is a small nodule noted in the adrenal gland") lead to inconsistent downstream handling — some get followed up, some get lost in dense report text. Structured reporting templates, with standardized categories and recommended actions attached to each finding, make incidental finding management reproducible across radiologists and over time.
A structured report separates the primary screening result (lung nodules, Lung-RADS category) from a distinct, clearly labeled incidental findings section, so that neither obscures the other.
Typical structured elements: • Coronary artery calcium: standardized ordinal score (none/mild/moderate/severe) in a dedicated field • Other incidental findings: organ, size, characterization, and an explicit recommendation category (no action / routine follow-up / further evaluation) • A clear statement of whether any finding requires communication beyond the standard report distribution (e.g., direct call to referring provider)
By attaching a standardized category and a pre-defined recommended action to each type of finding, structured reporting reduces variability between radiologists, makes downstream management auditable, and ensures the primary lung-cancer-screening message is not diluted by a long list of incidental observations.
This is the same principle behind standardized reporting systems used for the primary lung nodule assessment itself: consistent categories drive consistent management, whether the finding is a lung nodule or an incidental adrenal lesion.
A structured coronary calcium field is what turns "incidentally noted calcification" from a buried sentence into a discrete, trackable data point that can trigger a defined clinical pathway.
A well-triaged, well-structured finding still fails the patient if it is never actually communicated or acted upon. The final stage of incidental finding management is ensuring that both the patient and the referring provider clearly receive the finding and its recommended next step — with a coordination mechanism so significant findings do not silently get lost amid the primary lung-cancer-screening focus.
Communication failure — not detection failure — is one of the most common ways incidental findings cause harm: a significant finding is correctly identified and correctly categorized, but the recommendation never reaches anyone positioned to act on it.
Elements of a reliable pathway: • Every finding requiring action is stated explicitly, in plain language, in a location that is not buried in dense text • Findings above a significance threshold trigger direct communication to the referring provider (not just inclusion in the standard report) • The patient is informed of any finding that requires their own follow-up action (e.g., seeing a specialist) • A tracking or closed-loop system flags whether the recommended follow-up actually occurred, rather than assuming the report alone completes the clinician's responsibility
This final coordination step is what converts an accurate radiology report into an actual improvement in patient outcomes. Coronary calcium correctly identified as severe, or an adrenal lesion correctly flagged for further evaluation, only changes clinical care if the information reliably reaches — and is acted on by — the patient and their care team.
The most sophisticated triage and structured-reporting system still fails if a severe coronary calcium score or a significant adrenal finding sits unread in a report that never triggers a phone call — communication and follow-up coordination is the step that actually protects the patient.